Results for tag: "Cediranib"

Cediranib is a type of drug used to treat thyroid cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain proteins that can cause cancer cells to grow and divide. It is used in combination with other drugs to treat advanced thyroid cancer. Cediranib is typically used in combination with other drugs, such as sorafenib, lenvatinib, and cabozantinib. It is also used in combination with radioactive iodine therapy. Cediranib is generally well-tolerated, with the most common side effects being diarrhea, fatigue, and nausea. It is available in tablet form and is taken orally once daily. The cediranib market is a rapidly growing one, as it is increasingly being used to treat advanced thyroid cancer. It is a promising treatment option for patients with advanced thyroid cancer, as it has been shown to improve overall survival rates. Companies in the cediranib market include AstraZeneca, Bristol-Myers Squibb, Eisai, and Merck. Show Less Read more